Arrivent Biopharma News and Activities

Presence

Arrivent Biopharma develops cancer medicines and related drug development services. Its product focus includes targeted therapies and clinical programs for patients, healthcare providers, and partners in oncology care.

Arrivent Biopharma products and services overview:

Cancer therapies
Targeted medicines
Clinical development
Drug licensing

Revenue: ~$0 million

Employees: 60

Headquarters: Newtown Square, United States (USA)

Arrivent Biopharma is one of the...

Arrivent Biopharma is a company listed under the stock ticker AVBP (US).

Executives

View the org chart displaying its 21 main executives

Most searched biographies at Arrivent Biopharma

Popular executive movements at Arrivent Biopharma

Dengfeng Liu, Vice President of Chemistry, Manufacturing and Controls, has left the company (posted on July 7 2026).
Jerome Kern, Vice President and Controller, has left the company (posted on July 7 2026).
Janet Gee has joined the company as Associate Director, Financial Planning and Analysis (posted on April 22 2026).

Click here to view some more movements at Arrivent Biopharma

Create your alert
to follow the executive moves at Arrivent Biopharma.